Acceptability of Lactacyd Femina

To demonstrate the safety and acceptability of the gynaecological formulation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hygiene

Age range

18 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Sanofi-Aventis Administrative Office

Col. Coyoacan, Mexico

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Integral skin in the tested region

Exclusion criteria

Pregnancy or breastfeeding women
Use of anti-inflammatory or immune-suppression drugs
Topical medication use at the tested region
Active cutaneous gynaecological disease which may interfere in study results
Personal history of allergic disease at the area to be treated
Allergic or atopic history

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Treatment and study plan

Lactic acid

Drug

Once a day

Primary outcomes

Clinical and local tolerability

Time frame: After 21 days

Sponsors and collaborators

Lead sponsor

Sanofi

Industry

Registry information

Official study title

Safety Dermatological Evaluation: Acceptability With Gynaecological Follow up Lactacyd Femina

Acronym: LACTAFEM

Important dates

Study start: 2008
Primary completion: 2008
Study completion: 2008
First posted: Jul 10, 2008
Registry last updated: Jul 20, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed